大脑中动脉速度时间积分预测胎儿血红蛋白巴特病相关贫血
本研究为前瞻性收集数据的二次分析,纳入2008年1月至2023年12月泰国清迈医院高危孕妇的485例胎儿,评估大脑中动脉速度时间积分(MCA-VTI)预测血红蛋白巴特病的诊断效能,并与大脑中动脉收缩期峰值流速(MCA-PSV)比较。结果显示MCA-VTI的曲线下面积优于MCA-PSV,提示其可作为MCA-PSV的替代或补充指标。
要点
- MCA-VTI预测Hb巴特病的AUC为0.877(绝对值)和0.898(MoM),均优于MCA-PSV的0.842和0.854。
- 受累胎儿MCA-VTI绝对值显著高于未受累胎儿(7.9±1.8 vs 5.4±1.3,P<0.001)。
- 作者认为MCA-VTI可作为MCA-PSV的替代或补充用于检测胎儿贫血。
核心结论
- MCA-VTI预测胎儿Hb巴特病(间接反映贫血)的准确性优于MCA-PSV。
- 作者认为MCA-VTI可作为MCA-PSV的替代或补充用于检测胎儿贫血,尤其在Hb巴特病及其他病因中可能适用。
研究设计与样本
- 前瞻性收集数据的二次分析,纳入2008年1月至2023年12月泰国清迈医院母胎医学单元就诊的17-22周高危孕妇。
- 共485例胎儿(109例受累,376例未受累)纳入分析,最终诊断由脐带穿刺脐血血红蛋白分型确认。
主要发现
- 受累胎儿MCA-VTI绝对值显著高于未受累胎儿(7.9±1.8 vs 5.4±1.3,P<0.001),MoM值亦显著升高(1.5±0.3 vs 1.0±0.2,P<0.001)。
- MCA-VTI预测Hb巴特病的AUC:绝对值0.877(95%CI 0.836-0.917),MoM 0.898(95%CI 0.857-0.938)。
- MCA-PSV预测Hb巴特病的AUC:绝对值0.842(95%CI 0.795-0.889),MoM 0.854(95%CI 0.809-0.899)。
- MCA-VTI与MCA-PSV的AUC比较P<0.001。
临床怎么用
- 作者认为MCA-VTI可作为MCA-PSV的替代或补充用于检测胎儿贫血,尤其在Hb巴特病及其他病因中可能适用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the diagnostic performance of middle cerebral artery (MCA) velocity time integral (VTI) in predicting fetal hemoglobin (Hb) Bart's disease. METHODS: This was a secondary analysis of data collected prospectively from pregnant women at risk for fetal Hb Bart's disease assessed at 17-22 weeks' gestation, receiving care at the Maternal-Fetal Medicine Unit, Chiang Mai Hospital, Thailand, between January 2008 and December 2023. Each fetus underwent prenatal measurement of MCA peak systolic velocity (PSV) and MCA-VTI. Final diagnosis of Hb Bart's disease was confirmed by Hb typing of cord blood, obtained by cordocentesis. MCA-PSV and MCA-VTI were evaluated both as absolute values and multiples of median (MoM) normalized for gestational age. Diagnostic performance of MCA-PSV and MCA-VTI for predicting fetal Hb Bart's disease was evaluated and compared using area under the receiver-operating-characteristics curve (AUC), sensitivity, specificity and positive and negative predictive values. RESULTS: A total of 485 fetuses at risk for Hb Bart's disease (109 affected, 376 unaffected) met the inclusion criteria. Absolute MCA-VTI values were significantly higher in affected compared with unaffected fetuses (7.9 ± 1.8 vs 5.4 ± 1.3; P < 0.001) as were MoM values (1.5 ± 0.3 vs 1.0 ± 0.2; P < 0.001). The diagnostic performance of MCA-VTI was superior to that of MCA-PSV for detecting fetal anemia due to Hb Bart's disease, with AUCs of 0.877 (95% CI, 0.836-0.917) and 0.898 (95% CI, 0.857-0.938) for absolute MCA-VTI values (in cm) and MCA-VTI MoM, respectively, compared with 0.842 (95% CI, 0.795-0.889) and 0.854 (95% CI, 0.809-0.899) for absolute MCA-PSV values (in cm/s) and MCA-PSV MoM, respectively (P < 0.001). CONCLUSION: MCA-VTI is more accurate compared with MCA-PSV for predicting fetal Hb Bart's disease, which indirectly reflects anemia. This suggests that MCA-VTI could serve as an alternative or adjunct to MCA-PSV for detecting fetal anemia, particularly in cases of Hb Bart's disease and potentially for other etiologies. © 2025 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Parapob N, Jatavan P, Luewan S, et al. Middle cerebral artery velocity time integral as a predictor of fetal anemia using fetal hemoglobin Bart's disease as study model. Ultrasound Obstet Gynecol. 2025. PMID: 40150971. doi:10.1002/uog.29213
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。